Solid Biosciences Inc.·4

Feb 6, 6:01 PM ET

Ganot Ilan 4

4 · Solid Biosciences Inc. · Filed Feb 6, 2026

Research Summary

AI-generated summary of this filing

Updated

Solid Biosciences (SLDB) Director Ilan Ganot Sells 7,205 Shares

What Happened
Ilan Ganot, a director of Solid Biosciences (SLDB), sold 7,205 shares on February 4, 2026, for total proceeds of $46,414. The reported weighted-average price was $6.44 per share (sales executed in multiple trades at prices between $6.28 and $6.60). This was a sale (not a purchase) and was executed as a sell‑to‑cover to satisfy withholding taxes associated with the vesting of previously granted restricted stock units.

Key Details

  • Transaction date: February 4, 2026 (reported on Form 4 filed Feb 6, 2026).
  • Shares sold: 7,205; weighted-average price: $6.44; price range: $6.28–$6.60; proceeds: $46,414.
  • Shares owned after the transaction (per footnotes): 95,255 shares held individually, 4,042 held jointly with Annie Ganot, and 19,394 held in an irrevocable trust—totaling 118,691 beneficially reported shares.
  • Footnote highlights: sale was a non‑discretionary sell‑to‑cover to satisfy tax withholding for vested RSUs (durable automatic sales instruction adopted Sept 25, 2024). The filer can provide per‑trade price breakdown on request.
  • Timeliness: Filing appears timely (transaction 2/4/2026; Form 4 filed 2/6/2026).

Context
This was a routine sell‑to‑cover related to RSU vesting (tax withholding), not an opportunistic open‑market trade. Such transactions typically reflect tax obligations rather than a change in an insider’s view of the company; purchases by insiders are generally considered more informative about insider sentiment.

Insider Transaction Report

Form 4
Period: 2026-02-04
Ganot Ilan
Director
Transactions
  • Sale

    Common Stock

    [F1][F2]
    2026-02-04$6.44/sh7,205$46,41425,271 total(indirect: By Spouse)
Holdings
  • Common Stock

    [F3]
    99,297
  • Common Stock

    [F4]
    (indirect: See Foonote 4)
    19,394
Footnotes (4)
  • [F1]This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units pursuant to a durable automatic sales instruction letter adopted by Ms. Ganot on September 25, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Ms. Ganot.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.28 to $6.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form.
  • [F3]Represents 95,255 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.
  • [F4]Represents 19,394 shares held by Adam Ganot and Annie Ganot, and their successors, as the trustees for the Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017.
Signature
/s/ Kimberly Cornwell as attorney-in-fact for Ilan Ganot|2026-02-06

Documents

1 file
  • 4
    ownership.xmlPrimary

    4